Amend KRS 304.17A-148 to require that cost sharing for noninsulin drugs and certain equipment and supplies necessary for the treatment of diabetes not exceed certain cost-sharing thresholds; prohibit insurers from conducting or imposing utilization review for diabetes treatment prescribed by a health care provider; EFFECTIVE January 1, 2023.
No votes to display
introduced in House
to Committee on Committees (H)
Prefiled by the sponsor(s).
|Bill Text Versions||Format|
|No related documents.|
Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.